| Product NDC: | 0555-0033 | 
| Proprietary Name: | Chlordiazepoxide Hydrochloride | 
| Non Proprietary Name: | Chlordiazepoxide Hydrochloride | 
| Active Ingredient(s): | 10 mg/1 & nbsp; Chlordiazepoxide Hydrochloride | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | CAPSULE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0555-0033 | 
| Labeler Name: | Barr Laboratories Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA083116 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 19900930 | 
| Package NDC: | 0555-0033-02 | 
| Package Description: | 100 CAPSULE in 1 BOTTLE (0555-0033-02) | 
| NDC Code | 0555-0033-02 | 
| Proprietary Name | Chlordiazepoxide Hydrochloride | 
| Package Description | 100 CAPSULE in 1 BOTTLE (0555-0033-02) | 
| Product NDC | 0555-0033 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Chlordiazepoxide Hydrochloride | 
| Dosage Form Name | CAPSULE | 
| Route Name | ORAL | 
| Start Marketing Date | 19900930 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Barr Laboratories Inc. | 
| Substance Name | CHLORDIAZEPOXIDE HYDROCHLORIDE | 
| Strength Number | 10 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |